This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Rezurock▼ (Belumosudil) is intended for HCPs practising in Great Britain (England, Scotland and Wales) only.

The InTen Nurse Forum is a series of promotional meetings for GB HCPs only organised and funded by Sanofi. This Forum provides knowledge in the management of chronic Graft Versus Host Disease (GVHD), as well as an opportunity to hear from your peers on best practices.

What is chronic GvHD?

Length: 20:00

In this video you can learn from John the basics of chronic GvHD, how it impacts quality of life, its classification and measurement, and current treatment challenges.

John Murray is a nurse clinician in BMT at the Haematology and Transplant Unit of The Christie NHSFT where he first joined as the Transplant Coordinator and Apheresis nurse in 2001. Then he developed a new post of nurse clinician in BMT with a special interest in GvHD and late effects of transplant.

He has been Chair of the EBMT UK NAP group and also Chair of the EBMT scientific committee. He became President of EBMT NG in 2017, serving for 4 years and is currently a Past President. He gives regular presentations on issues related to transplantation with a special interest in GvHD. John is also Co-chair of the Equality Diversity and Inclusion committee of EBMT.

InTen Nurse Forum - ACCEND Framework


InTen Nurse Forum - ACCEND Framework


Purple background
Help us to shape our future events

There will be more InTen Nurse Forum events in the coming months and we want to hear from you. 
Let us know what topics you are interested in by clicking below and fill out the form. Your voice will shape our future events.

Rezurock logo with man

Get the latest updates about REZUROCK


This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study


Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only​

1/2
Rezurock logo with man

Get the latest updates about REZUROCK


This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study


Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only​

Get in touch with the Transplant Team

MAT-XU-2401966 (v1.0) Date of Preparation: June 2024